HNRNPA1 de novo Variant Associated with Early Childhood Onset, Rapidly Progressive Generalized Myopathy
Journal of Neuromuscular Diseases · 2024
DOI: 10.3233/jnd-240050 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Neuromuscular Diseases, 2024. Verfasst von Andreas Roos und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropediatrics and Neuromuscular Centre for Children and Adolescents, Center for Translational Neuro- and Behavioral Sciences, Univers…. Hauptthemen laut MEDLINE: Heterogeneous Nuclear Ribonucleoprotein A1, Muscular Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
HNRNPA1 variants are known to cause degenerative motoneuron and muscle diseases which manifests in middle age or later. We report on a girl with early childhood onset, rapidly progressive generalized myopathy including ultrastructural findings in line with a proteinopathy. Proteomics of patient-derived muscle and combined screening of genomic data for copy number variations identified a HNRNPA1 de novo intragenic deletion as causative for the phenotype. Our report expands the spectrum of HNRNPA1-related diseases towards early-childhood onset and adds HNRNPA1 to the growing list of ALS and myopathy genes for which certain mutations may cause severe pediatric phenotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuropediatrics and Neuromuscular Centre for Children and Adolescents, Center for Translational Neuro- and Behavioral Sciences, University Duisburg-Essen, Essen, Germany.
- Department of Neurology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
- Department of Medicine, Division of Neurology, Children' s Hospital of Eastern Ontario Research Institute, The Ottawa Hospital, and Brain and Mind Research Institute, University of Ottawa, Ottawa, Canada.
- Department of Paediatrics, Division of Neuropediatrics and Social Pediatrics, RWTH Aachen University Hospital, Aachen, Germany.
- Leibniz-Institut für Analytische Wissenschaften - ISAS - e.V. Dortmund, Germany.
- John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
Zitieren
APA
Roos, A., Häusler, M., Kollipara, L., Topf, A., Preusse, C., Stucka, R., Nolte, K., Strom, T., Berutti, R., Jiang, X., Koll, R., Lochmüller, H., Schacht, S. M., Zahedi, R. P., Weis, J., & Senderek, J. (2024). HNRNPA1 de novo Variant Associated with Early Childhood Onset, Rapidly Progressive Generalized Myopathy. Journal of Neuromuscular Diseases. https://doi.org/10.3233/jnd-240050
Vancouver
Roos A, Häusler M, Kollipara L, Topf A, Preusse C, Stucka R, et al. HNRNPA1 de novo Variant Associated with Early Childhood Onset, Rapidly Progressive Generalized Myopathy. Journal of Neuromuscular Diseases. 2024. doi:10.3233/jnd-240050
BibTeX
@article{Roos2024,
author = {Roos, Andreas and Häusler, Martin and Kollipara, Laxmikanth and Topf, Ana and Preusse, Corinna and Stucka, Rolf and Nolte, Kay and Strom, Tim and Berutti, Riccardo and Jiang, Xuehui and Koll, Randi and Lochmüller, Hanns and Schacht, Sabine Maria and Zahedi, René P and Weis, Joachim and Senderek, Jan},
title = {HNRNPA1 de novo Variant Associated with Early Childhood Onset, Rapidly Progressive Generalized Myopathy},
journal = {Journal of Neuromuscular Diseases},
year = {2024},
doi = {10.3233/jnd-240050}
}
EUVIMED